Daratumumab – a CD38 mAb – for the Treatment of Relapsed /Refractory Multiple Myeloma Patients: Preliminary Efficacy and PK Data from a Multicenter Phase I/II Study.

Plesner, T. (Foredragsholder)

Aktivitet: Foredrag og mundtlige bidragForedrag og præsentationer i privat eller offentlig virksomhed

Periode23. aug. 201225. aug. 2012
Begivenhedstitel7th International Workshop on Waldenström's Macroglobulinemia and Symposium on Advances in Multiple Myeloma
BegivenhedstypeWorkshop
PlaceringNewport, Rhode Island, USA